GROUP ONE TRADING, L.P. - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 175 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$995,487
+17.4%
53,694
-30.0%
0.00%0.0%
Q2 2023$847,893
+4.2%
76,663
+26.6%
0.00%0.0%
Q1 2023$813,375
+305.1%
60,564
+273.2%
0.00%
Q4 2022$200,765
-82.9%
16,230
-80.7%
0.00%
-100.0%
Q3 2022$1,174,000
+29.6%
84,141
+51.1%
0.00%
+100.0%
Q1 2022$906,000
+271.3%
55,700
+272.3%
0.00%
Q4 2021$244,000
+1933.3%
14,963
+14863.0%
0.00%
Q4 2019$12,000
-99.7%
100
-99.8%
0.00%
-100.0%
Q3 2019$3,544,000
+229.7%
53,400
+316.8%
0.03%
+222.2%
Q2 2018$1,075,000
-28.5%
12,812
-47.6%
0.01%
-40.0%
Q1 2018$1,504,000
+27.1%
24,444
+20.7%
0.02%
+87.5%
Q4 2017$1,183,000
+33.4%
20,251
+32.6%
0.01%0.0%
Q3 2017$887,000
+74.3%
15,278
+263.4%
0.01%
+60.0%
Q2 2017$509,000
-45.7%
4,204
-49.2%
0.01%
-54.5%
Q1 2017$937,000
+73.5%
8,282
+66.8%
0.01%
+120.0%
Q4 2016$540,000
+2.3%
4,966
+54.8%
0.01%
-16.7%
Q3 2016$528,000
+41.9%
3,208
+23.0%
0.01%
+50.0%
Q2 2016$372,000
+1.6%
2,608
+6.5%
0.00%0.0%
Q4 2015$366,000
+1364.0%
2,448
+1521.2%
0.00%
Q3 2015$25,000
-94.3%
151
-91.8%
0.00%
-100.0%
Q2 2015$442,000
-87.7%
1,831
-85.7%
0.01%
-89.5%
Q1 2015$3,605,000
+2020.6%
12,784
+1683.0%
0.06%
+1800.0%
Q3 2014$170,000
-86.0%
717
-80.5%
0.00%
-85.0%
Q1 2014$1,211,0003,6710.02%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders